Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A McCoy

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Journal of Biological Chemistry|July 22, 2022
Mechanistic insights on novel small molecule allosteric activators of cGMP-dependent protein kinase PKG1αPaul Tawa, Lei Zhang, Essam Metwally, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) InhibitorsXiaohua Huang, Gerald W Shipps, Cliff C Cheng, et al.
ACS Chemical Biology|February 8, 2018
Discovery of Selective RNA-Binding Small Molecules by Affinity-Selection Mass SpectrometryNoreen F Rizvi, John A Howe, Ali Nahvi, et al.
Journal for Immunotherapy of Cancer|August 19, 2025
Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapyThierry O Fischmann, Daniel Malashock, Eunseon Ahn, et al.
Molecular Cancer Therapeutics|April 2, 2020
Biophysical and Immunological Characterization and <i>In Vivo</i> Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody PembrolizumabBeth Hutchins, Gary C Starling, Mark A McCoy, et al.
Journal of Medicinal Chemistry|March 17, 2022
Discovery of Insulin Receptor Partial Agonists MK-5160 and MK-1092 as Novel Basal Insulins with Potential to Improve Therapeutic IndexDmitri A Pissarnitski, Ahmet Kekec, Lin Yan, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Journal of Biological Chemistry|July 22, 2022
Mechanistic insights on novel small molecule allosteric activators of cGMP-dependent protein kinase PKG1αPaul Tawa, Lei Zhang, Essam Metwally, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) InhibitorsXiaohua Huang, Gerald W Shipps, Cliff C Cheng, et al.
ACS Chemical Biology|February 8, 2018
Discovery of Selective RNA-Binding Small Molecules by Affinity-Selection Mass SpectrometryNoreen F Rizvi, John A Howe, Ali Nahvi, et al.
Journal for Immunotherapy of Cancer|August 19, 2025
Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapyThierry O Fischmann, Daniel Malashock, Eunseon Ahn, et al.
Molecular Cancer Therapeutics|April 2, 2020
Biophysical and Immunological Characterization and <i>In Vivo</i> Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody PembrolizumabBeth Hutchins, Gary C Starling, Mark A McCoy, et al.
Journal of Medicinal Chemistry|March 17, 2022
Discovery of Insulin Receptor Partial Agonists MK-5160 and MK-1092 as Novel Basal Insulins with Potential to Improve Therapeutic IndexDmitri A Pissarnitski, Ahmet Kekec, Lin Yan, et al.
Pageof 3